{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:16Z","timestamp":1790726416914,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,20]],"date-time":"2027-05-20T00:00:00Z","timestamp":1810771200000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jvir.2026.108819","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:07:59Z","timestamp":1776787679000},"page":"108819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-248X","authenticated-orcid":false,"given":"Daana","family":"Bajnauth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-386X","authenticated-orcid":false,"given":"Amy","family":"Deipolyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8423-4119","authenticated-orcid":false,"given":"Frank","family":"Annie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-3947","authenticated-orcid":false,"given":"Yolanda","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2026.108819_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4251\/wjgo.v12.i2.228","article-title":"Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: a systematic review","volume":"12","author":"Feretis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib2","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ejca.2011.06.024","article-title":"Hepatic resection for metastatic breast cancer: a systematic review","volume":"47","author":"Chua","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2026.108819_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","article-title":"Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients","volume":"21","author":"Saxena","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.115.165050","article-title":"Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single-center experience in 81 patients","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2026.108819_bib5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jvir.2014.07.007","article-title":"Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy","volume":"25","author":"Gordon","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108819_bib6","article-title":"Selective internal radiation therapy of metastatic breast cancer to the liver: a meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib7","article-title":"Transarterial yttrium-90 glass microsphere radioembolization of chemotherapy-refractory breast cancer liver metastases: results of a single institution retrospective study","volume":"7","author":"Barakat","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00270-022-03254-4","article-title":"Study protocol: efficacy and safety of radioembolization (REM) as an early modality (EM) therapy for metastatic breast cancer (BR) to the liver with Y90 (REMEMBR Y90)","volume":"45","author":"Wu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.108819_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jvir.2015.05.032","article-title":"KRAS status as an independent prognostic factor for survival after yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastases","volume":"26","author":"Lahti","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108819_bib11","doi-asserted-by":"crossref","first-page":"23529","DOI":"10.18632\/oncotarget.15278","article-title":"PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases","volume":"8","author":"Ziv","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvir.2026.108819_bib12","doi-asserted-by":"crossref","first-page":"32523","DOI":"10.18632\/oncotarget.25992","article-title":"Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases","volume":"9","author":"Dendy","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvir.2026.108819_bib13","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2018.04.018","article-title":"Association of PI3K pathway mutations with early positron-emission tomography\/CT imaging response after radioembolization for breast cancer liver metastases: results of a single-center retrospective pilot study","volume":"29","author":"Deipolyi","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108819_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2010.03.014","article-title":"Dose-rate effects in external beam radiotherapy redux","volume":"95","author":"Ling","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib15","series-title":"Advances in radiation biology","first-page":"245","article-title":"Dose rate effects in cell and animal systems","author":"Gerweck","year":"1992"},{"key":"10.1016\/j.jvir.2026.108819_bib16","first-page":"18","article-title":"The dose-rate effect and the linear-quadratic model","volume":"20","author":"Wheldon","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jvir.2026.108819_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(82)90517-X","article-title":"Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships","volume":"8","author":"Thames","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2026.108819_bib18","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3390\/cancers14174234","article-title":"Quantifying the effects of combination trastuzumab and radiation therapy in human epidermal growth factor receptor 2-positive breast cancer","volume":"14","author":"Bloom","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2026.108819_bib19","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.3390\/cancers16233899","article-title":"Clinical relevance of TP53 mutation and its characteristics in breast cancer with long-term follow-up date","volume":"16","author":"Hwang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2026.108819_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-94-017-9211-0_8","article-title":"Mutant p53 and the response to chemotherapy and radiation","volume":"85","author":"Tchelebi","year":"2014","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.jvir.2026.108819_bib21","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/molecules24091739","article-title":"Small molecule inhibitors of KDM5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B","volume":"24","author":"Pippa","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jvir.2026.108819_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-024-02011-0","article-title":"KDM5 family as therapeutic targets in breast cancer: pathogenesis and therapeutic opportunities and challenges","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jvir.2026.108819_bib23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41467-019-10102-6","article-title":"The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription","volume":"10","author":"Malik","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jvir.2026.108819_bib24","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.34883","article-title":"Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS\/STING-mediated immune responses","volume":"154","author":"Mancarella","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jvir.2026.108819_bib25","article-title":"A systematic review of the role of runt-related transcription factor 1 (RUNX1) in the pathogenesis of hematological malignancies in patients with inherited bone marrow failure syndromes","volume":"14","author":"Illango","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jvir.2026.108819_bib26","first-page":"145","article-title":"The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies","volume":"43","author":"Yokota","year":"2020","journal-title":"Mol Cells"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326008304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326008304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:12:11Z","timestamp":1790723531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044326008304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1051044326008304"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108819","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2026","name":"copyright","label":"Copyright"}],"article-number":"108819"}}